BIOTRONIK expands peripheral portfolio with new treatment tool for interventions in complex lesions

Carnelian Support catheter from Tokai Medical Products now commercially available

Carnelian Support is now available in the UK

BIOTRONIK has launched the Carnelian Support catheter, designed to improve access for treatment of tortuous and highly-calcified lesions.

Carnelian Support is indicated for the exchange and support of guidewires into peripheral vasculature.

Up to 40% of patients with symptomatic peripheral artery disease present with a chronic total occlusion (CTO).

If only a guidewire is used to cross the CTO, there is a risk it will buckle once it encounters resistance by atherosclerotic plaque, stopping it from advancing further.

Carnelian Support is designed to prevent this buckling by enhancing guidewire control and allowing CTO crossing.

Carnelian Support comes in five models and has a low tip profile of 1.6 and 1.8 French.

Its tungsten braided shaft and platinum marker contribute to high kink resistance and excellent radiopaque visibility.

And the catheter’s multi-segment shaft design provides a smooth transition from the soft distal tip allowing trackability to the stiffer proximal part that ensures additional push.

The launch of the Carnelian Support marks the start of a partnership between BIOTRONIK and Tokai Medical Products.

“At BIOTRONIK we believe that innovation matters,” said Dr Alexander Uhl, senior vice president of corporate marketing at BIOTRONIK.

“Especially for those patients with complex lesions; interventionalists need the best tools available. This is why we are bringing this innovative technology, already well established and proven on the Japanese market to the European market.”

Companies